Orchid Pharma (BOM:524372) Total Liabilities : ₹4,109 Mil (As of Sep. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Orchid Pharma Total Liabilities?

Orchid Pharma's Total Liabilities for the quarter that ended in Sep. 2024 was ₹4,109 Mil.

Orchid Pharma's quarterly Total Liabilities declined from Mar. 2024 (₹3,844.08 Mil) to Jun. 2024 (₹0.00 Mil) but then increased from Jun. 2024 (₹0.00 Mil) to Sep. 2024 (₹4,109.01 Mil).

Orchid Pharma's annual Total Liabilities increased from Mar. 2022 (₹4,631.83 Mil) to Mar. 2023 (₹5,365.57 Mil) but then declined from Mar. 2023 (₹5,365.57 Mil) to Mar. 2024 (₹3,844.08 Mil).

Orchid Pharma Total Liabilities Historical Data

The historical data trend for Orchid Pharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orchid Pharma Total Liabilities Chart

Orchid Pharma Annual Data

Trend

Mar13

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

6,939.21

5,843.44

4,631.83

5,365.57

3,844.08

Orchid Pharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															3,842.44	-	3,844.08	-	4,109.01

Orchid Pharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Orchid Pharma's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2599.743	+	(1207.998	+	-1.4210854715202E-14
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	36.337)
	=	3,844

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	15538.739	-	11694.661
	=	3,844

Orchid Pharma's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2811.013	+	(1261.415	+	36.581
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	4,109

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	16351.441	-	12242.432
	=	4,109

Orchid Pharma Total Liabilities Related Terms

Thank you for viewing the detailed overview of Orchid Pharma's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Orchid Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orchid Pharma Ltd (BOM:524372) » Definitions » Total Liabilities

Traded in Other Exchanges

ORCHPHARMA:India

Address

Sector 74A, 15th Floor, Tower-1, DLF Corporate Greens, Narsinghpur, Gurugram, HR, IND, 122004

Website

http://www.orchidpharma.com

Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment which is Cephalosporin Pharmaceuticals, in which the Company drives its major sales through Active Pharmaceuticals Ingredients. The company produces various products for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotics, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. The company operates its business throughout the Indian region.

Orchid Pharma Headlines

No Headlines